Tenax Therapeutics
Price & Volume
Stats
See more52W Range | $1.31-$19.40 |
Market Cap | $76.9M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.39 |
News
See moreYahoo Finance • 5 days ago
Tenax Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Yahoo Finance • 3 months ago
Tenax, Sionna plunge; MarineMax jumps premarket on reported buyout
Yahoo Finance • 3 months ago
Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Yahoo Finance • 4 months ago
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Mr. Christopher T. Giordano |
Address | 101 Glen Lennox Drive, Chapel Hill, NC, United States, 27517 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 14 |